HeartBeam Inc. Recognized as Global Leader in Portable Cardiac Diagnostics Innovation

HeartBeam Inc. (NASDAQ: BEAT), a medical-technology company developing advanced electrocardiogram solutions, has been recognized as a Global IP and Technology Leader in Portable Cardiac Diagnostics according to PatentVest's "Total Cardiac Intelligence" report. The company ranked second worldwide in 12-lead ECG innovation among 243 firms analyzed, trailing only GE Healthcare. This recognition underscores HeartBeam's growing influence in the next generation of cardiac monitoring technology and highlights the rapid maturation of its proprietary synthesis-ECG system.

The company's technology captures the heart's electrical signals in three noncoplanar dimensions and synthesizes them into a 12-lead ECG. This unique approach allows physicians to obtain cardiologist-level ECG data from compact devices that can be used by patients or clinicians far from traditional hospital settings. By addressing one of modern medicine's most persistent challenges—delivering high-quality cardiac monitoring for arrhythmia assessment wherever patients are—HeartBeam is positioned to transform cardiac care delivery. The company is currently cleared for arrhythmia assessment, with ischemia monitoring identified as a future goal for the technology.

HeartBeam is creating what it describes as the first-ever cable-free 12-lead ECG capable of capturing the heart's electrical signals from three dimensions. This platform technology is designed for use in portable devices that can deliver actionable heart intelligence wherever the patient is located. The system enables physicians to identify cardiac health trends and acute conditions and direct patients to appropriate care outside of medical facilities, potentially redefining the future of cardiac health management. The company's intellectual property portfolio includes 13 U.S. and 4 international-issued patents related to technology enablement.

The recognition by PatentVest comes as HeartBeam continues to develop its cardiac monitoring solutions. The company's technology represents a significant advancement in making sophisticated cardiac diagnostics accessible beyond traditional clinical environments. This development has implications for improving cardiac care accessibility, particularly for patients in remote locations or those requiring continuous monitoring. The ranking among 243 firms analyzed demonstrates the competitive positioning of HeartBeam's innovation in the global medical technology landscape. Additional information about the company is available at https://www.HeartBeam.com.